ursolic acid has been researched along with Atherosclerosis in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erdmann, J; Kujaciński, M; Wiciński, M | 1 |
| Bai, G; Bai, Y; Han, Y; Hao, E; Hou, X; Hou, Y; Liu, K; Liu, Y; Ma, X; Zhang, J | 1 |
| Huang, N; Li, W; Liu, R; Liu, X; Liu, Z; Xing, Q; Yan, Q | 1 |
| Hao, Z; Li, Q; Zeng, X; Zhao, W | 1 |
| Fan, D; Iwanowycz, S; Leng, S; Razani, B; Saaoud, F; Sergin, I; Wang, J; Wang, Y | 1 |
| Gao, H; Han, Y; Jiang, Q; Li, P; Tian, R; Wang, C | 1 |
| Gao, H; Hao, R; Jiang, Q; Wang, C; Wang, W | 1 |
| Asmis, R; Ullevig, SL; Zamora, D; Zhao, Q | 1 |
| Tannock, LR | 1 |
| Han, GZ; Jin, Y; Liu, KX; Liu, P; Liu, YX; Lv, YY; Sun, HJ; Wu, T; Zhou, Q | 1 |
1 review(s) available for ursolic acid and Atherosclerosis
| Article | Year |
|---|---|
Beneficial Effects of Ursolic Acid and Its Derivatives-Focus on Potential Biochemical Mechanisms in Cardiovascular Conditions.
Topics: Animals; Atherosclerosis; Cardiovascular Diseases; Cardiovascular System; Clinical Trials as Topic; Dietary Supplements; Female; Humans; Male; Myocytes, Cardiac; Triterpenes; Ursolic Acid; Vasodilation | 2021 |
9 other study(ies) available for ursolic acid and Atherosclerosis
| Article | Year |
|---|---|
Ursolic acid inhibits the cholesterol biosynthesis and alleviates high fat diet-induced hypercholesterolemia via irreversible inhibition of HMGCS1 in vivo.
Topics: Animals; Atherosclerosis; Cholesterol; Cholesterol, LDL; Coenzyme A Ligases; Diet, High-Fat; Hypercholesterolemia; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Triterpenes; Ursolic Acid | 2022 |
Explore the mechanism of ursolic acid acting on atherosclerosis through network pharmacological and bioinformatics methods.
Topics: Atherosclerosis; Computational Biology; Databases, Factual; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; MicroRNAs; Ursolic Acid | 2023 |
Ursolic Acid Attenuates Atherosclerosis in ApoE
Topics: Animals; Anti-Inflammatory Agents; Aorta; Apolipoproteins E; Atherosclerosis; Disease Models, Animal; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myeloid Differentiation Factor 88; NF-kappa B; Reactive Oxygen Species; RNA, Small Interfering; Scavenger Receptors, Class E; Signal Transduction; Toll-Like Receptor 4; Triterpenes; Ursolic Acid | 2018 |
Ursolic acid enhances macrophage autophagy and attenuates atherogenesis.
Topics: Animals; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP Binding Cassette Transporter, Subfamily G, Member 1; Autophagy; Autophagy-Related Protein 5; Autophagy-Related Proteins; Carrier Proteins; Cholesterol; Diet, Western; Gene Expression Regulation; Inflammation; Interleukin-1beta; Lipopolysaccharides; Macrophages; Mice; Mice, Knockout; RAW 264.7 Cells; Receptors, LDL; Triterpenes; Ursolic Acid | 2016 |
Ursolic acid induced anti-proliferation effects in rat primary vascular smooth muscle cells is associated with inhibition of microRNA-21 and subsequent PTEN/PI3K.
Topics: Animals; Atherosclerosis; Cell Proliferation; Chromones; Gene Expression Regulation; Gene Expression Regulation, Enzymologic; Heterocyclic Compounds, 3-Ring; Male; MicroRNAs; Morpholines; Muscle, Smooth, Vascular; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; PTEN Phosphohydrolase; Rats; Rats, Sprague-Dawley; Signal Transduction; Triterpenes; Ursolic Acid | 2016 |
SIRT1/Atg5/autophagy are involved in the antiatherosclerosis effects of ursolic acid.
Topics: Acetylation; Animals; Atherosclerosis; Autophagy; Autophagy-Related Protein 5; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Lipoproteins, LDL; Male; Quail; Sirtuin 1; Triterpenes; Ursolic Acid | 2016 |
Ursolic acid protects diabetic mice against monocyte dysfunction and accelerated atherosclerosis.
Topics: Animals; Aortic Diseases; Atherosclerosis; Cardiovascular Agents; Cell Line; Chemokine CCL2; Chemotaxis, Leukocyte; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Dose-Response Relationship, Drug; Female; Humans; Hyperlipidemias; Kidney; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Oxidative Stress; Receptors, CCR2; Receptors, LDL; Resveratrol; Stilbenes; Time Factors; Triterpenes; Ursolic Acid | 2011 |
Ursolic acid effect on atherosclerosis: apples and apples, or apples and oranges?
Topics: Animals; Aortic Diseases; Apoptosis; Atherosclerosis; Cardiovascular Agents; Caspases; Diabetes Mellitus, Experimental; Diabetic Angiopathies; DNA Damage; Female; Human Umbilical Vein Endothelial Cells; Humans; Male; Mitochondria; Monocytes; Plaque, Atherosclerotic; Triterpenes; Tumor Suppressor Protein p53; Ursolic Acid | 2011 |
Ursolic acid suppresses IL-6 induced C-reactive protein expression in HepG2 and protects HUVECs from injury induced by CRP.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Atherosclerosis; C-Reactive Protein; Cell Proliferation; Cells, Cultured; Down-Regulation; Endothelium, Vascular; Hep G2 Cells; Hepatocytes; Human Umbilical Vein Endothelial Cells; Humans; Interleukin-6; Osmolar Concentration; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Scavenger Receptors, Class E; Triterpenes; Up-Regulation; Ursolic Acid; Vascular Cell Adhesion Molecule-1 | 2012 |